Roslyn Bernstein Mannon MD
Kidney & Pancreas Transplantation
Professor, Medicine, University of Nebraska Medical Center
Join to View Full Profile
983040 Nebraska Medical CenterOmaha, NE 68198
Phone+1 402-559-9227
Fax+1 402-559-9504
Dr. Mannon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Vice Chair of Research,
Department of Medicine
Associate Chief for Research, Division of Nephrology
Education & Training
Duke University HospitalFellowship, Nephrology, 1988 - 1990- Duke University HospitalResidency, Internal Medicine, 1985 - 1988
Duke University School of MedicineClass of 1985
Certifications & Licensure
NE State Medical License 2020 - 2026
AL State Medical License 2008 - 2025
NC State Medical License 1987 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014-2020
- Fellow American Society of Transplantation, 2015
- President American Society of Transplantation, 2012
- Join now to see all
Clinical Trials
- Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation Start of enrollment: 2011 Sep 01
- Optimization of NULOJIX® Usage Towards Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation Start of enrollment: 2013 Feb 01
- Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen Start of enrollment: 2013 Jul 01
Publications & Presentations
PubMed
- Combination Automated Microfluidics Measurement of Urine CCL2, CXCL9, CXCL10 and VEGF-A for Monitoring Patients with a Kidney Transplant.Michael E Seifert, Alvin T Kho, Lea Sheward, Nancy Rodig, Sarah Goldberg
Clinical Journal of the American Society of Nephrology. 2025-03-11 - Biomarkers of Rejection in Kidney Transplantation.Scott G Westphal, Roslyn B Mannon
American Journal of Kidney Diseases. 2025-03-01 - 3 citationsSubthreshold rejection activity in many kidney transplants currently classified as having no rejection.Philip F Halloran, Katelynn S Madill-Thomsen, Georg Böhmig, Jonathan Bromberg, Klemens Budde
American Journal of Transplantation. 2025-01-01
Journal Articles
- Repeat Kidney Transplant Recipients with Active Rejection Have Elevated Donor‐Derived Cell‐Free DNARoslyn B Mannon, Jonathan S Bromberg, Shikha G Mehta, American journal of transplantation
- Author Correction: Metformin Reverses Established Lung Fibrosis in a Bleomycin ModelMorgan L Locy, Roslyn B Mannon, Sunad Rangarajan, Edward Abraham, Nature
- Metformin Reverses Established Lung Fibrosis in a Bleomycin ModelSunad Rangarajan, Morgan L Locy, Edward Abraham, Roslyn B Mannon, Nature
- Join now to see all
Press Mentions
Noninvasive Tests to Detect Kidney Transplant Rejection: The Search ContinuesAugust 12th, 2022- #NephMadness 2021: Introducing the Blue Ribbon PanelFebruary 18th, 2021
- Eurofins Viracor, Cleveland Clinic Sign License Deal for Kidney Transplant Rejection Biomarker TestFebruary 8th, 2021
- Join now to see all
Grant Support
- An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)OMAHA VA MEDICAL CENTER2024–2029
- An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)OMAHA VA MEDICAL CENTER2024–2029
- An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)OMAHA VA MEDICAL CENTER2024–2029
- An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)OMAHA VA MEDICAL CENTER2024–2029
- 4/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical CenterUNIVERSITY OF ALABAMA AT BIRMINGHAM2017–2028
- 4/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical CenterUNIVERSITY OF ALABAMA AT BIRMINGHAM2017–2028
- Chronic Allograft Nephropathy (Can):Translational Approaches To The PathogenesisNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
- Kidney/Pancreas Allograft Rejection: Clinical Studies And Technology DevelopmentNational Institute Of Diabetes And Digestive And Kidney Diseases2007
- Chronic Allograft Nephropathy (Can):Translational ApproaNational Institute Of Diabetes And Digestive And Kidney Diseases2006
- Connective Tissue GF In Chronic Allograft NephropathyNational Institute Of Diabetes And Digestive And Kidney Diseases2005
- Allograft Neuropathy And Connective Tissue Growth FactorNational Institute Of Diabetes And Digestive And Kidney Diseases2004
- The Role Of Connective Tissue Growth Factor In Chronic ANational Institute Of Diabetes And Digestive And Kidney Diseases2003
- Regulation Of Thymocyte Apoptosis By Thromboxane A2National Institute Of Allergy And Infectious Diseases1996–2000
Professional Memberships
- Fellow
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
